CSL provides COVID-19 update and reaffirms guidance

The CSL Limited (ASX:CSL) share price will be on watch on Thursday after releasing a COVID-19 update and reaffirming its guidance…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price will be on watch on the S&P/ASX 200 Index (ASX: XJO) on Thursday.

This follows the release of a COVID-19 update by the biotherapeutics giant.

What did CSL announce?

This morning CSL provided investors with a comprehensive update on how the COVID-19 pandemic is impacting its business.

According to the release, plasma collections are expected to be impacted by the pandemic.

However, the company is optimistic it will be able to mitigate this through a number of initiatives. These include collection centres being designated essential critical infrastructure, safe passage letters provided to staff and donors, and FDA initiatives to release plasma earlier in the cycle.

In addition to this, it notes that it has the potential to accelerate plasma collection post crisis and expects an increase in new donors due to the economic downturn. If this eventuates, it should limit any impact to its sales in FY 2021. 

Commercial update.

CSL also provided an update on its commercial activities. It reminded investors that the majority of its products are life saving or life extending and not discretionary.

As a result, current demand is consistent with expectations. Furthermore, requests for IVIG are elevated and influenza vaccine demand is strong.

Positively, there are currently no items out of stock and no interruptions to its supply chain.

One small negative is that there are modest delays expected in capital projects and clinical trials. However, management is aiming to accelerate activity post crisis to ensure there are no material changes to its original plan.

Outlook.

CSL has become one of only a handful of companies that have been able to maintain their guidance in FY 2020. Management has reaffirmed its FY 2020 profit guidance of ~US$2,110 million to US$2,170 million in constant currency.

The company also notes that it is in a strong capital position with an estimated US$1.1 billion of available liquidity.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »